Intellectual Property
Entresto (Sacubitril/Valsartan) Patent Litigation
Pending actions
1
Historical total
28
Resolved / remanded
27
Winding Down. Few actions remain relative to the docket’s history. Of 28 lawsuits ever part of this litigation, 1 remain active.
About this litigation
Entresto (Sacubitril/Valsartan) Patent Litigation is a federal multidistrict litigation classified by the Judicial Panel on Multidistrict Litigation as a Intellectual Property docket. It was centralized on March 27, 2020 before Richard G. Andrews, Sr. District Judge, in the D. Delaware.
As of the August 3, 2026 JPML report, 1 individual lawsuits are pending in this MDL. Cases coordinated in an MDL keep their separate identity — they are managed together only for pretrial proceedings. Learn how MDLs work.
Related Intellectual Property MDLs
View categoryRare Breed Triggers Patent Litigation
59
pending actions
MDL 3176
E.D. Texas
OpenAI, Inc., Copyright Infringement Litigation
19
pending actions
MDL 3143
S.D. New York
Denosumab Patent Litigation
8
pending actions
MDL 3138
D. New Jersey
Neo Wireless, LLC, Patent Litigation
7
pending actions
MDL 3034
E.D. Michigan